Biological processes chiral molecules

The term chiral recognition refers to a process m which some chiral receptor or reagent interacts selectively with one of the enantiomers of a chiral molecule Very high levels of chiral recognition are common m biological processes (—) Nicotine for exam pie IS much more toxic than (+) nicotine and (+) adrenaline is more active than (—) adrenaline m constricting blood vessels (—) Thyroxine an ammo acid of the thyroid gland that speeds up metabolism is one of the most widely used of all prescription... 

Abstract To appreciate the technological potential of controlled molecular-level motion one only has to consider that it lies at the heart of virtually every biological process. When we learn how to build synthetic molecular motors and machines that can interface their effects directly with other molecular-level sub-structures and the outside world it will add a new dimension to functional molecule and materials design. In this review we discuss both the influence of chirality on the design of molecular level machines and, in turn, how molecular level machines can control the expression of chirality of a physical response to an inherently achiral stimulus. 

The enantiomers of a chiral compound have identical physical and chemical properties. Accordingly, abiotic processes such as air-water exchange, sorption, and abiotic transformation are generally identical for both enantiomers. However, biochemical processes may differ among stereoisomers because they can interact differentially with other chiral molecules such as enzymes and biological receptors. Thus, enantiomers may have different biological and toxicological effects. 

Chirality plays a major role in biological processes and enantiomers of a particular molecule can often have different physiological properties. In some cases, enantiomers may have similar pharmacological properties with different potencies for example, one enantiomer may play a positive pharmacological role, while the other can be toxic. For this reason, advancements in asymmetric synthesis, especially in the pharmaceutical industry and life sciences, has led to the need to assess the enantiomeric purity of drugs. Chromatographic chiral separation plays an important role in this domain. Today, there are a large number of chiral stationary phases on the market that facilitate the assessment of enantiomeric purity. 

The purpose of this article is to provide an overview of the different types of chemical and biological catalysis currently available to the pharmaceutical industry in the process area. In other words, these transformations can be performed at scale. The types of catalysts that have been used are given together with systems that show potential for future application. The chemocatalytic area has addressed the synthesis of aromatic and heterocyclic compounds, which are common classes in pharmaceutically active compounds, whereas biocatalyst applications tend to be aimed toward the production of chiral molecules. 

Enantiomers show different characteristics in terms of their biological properties. The molecules involved in the metabolisms of animals and plants are mostly chiral molecules and the reactions of different enantiomers occur at different rates. We may think of the glove and hand analogy although we are able to put a left-handed glove onto a right hand, this process takes a lot of time and the glove doesn t fit correctly. 

When it became clear that the two IS-enantiomers of metolachlor were responsible fijr most of the biological activity (see Fig. 1), there was the obvious challenge of finding a chemically and economically feasible production process for the active stereoisomers. Many methods allow the enantioselective synthesis of chiral molecules (that is the preferential formation of one enantiomer instead of the usual racemate). However, the selective preparation of S-metolachlor was a formidable task, due to the very special structure and properties of this molecule and also because of the extremely efficient production process for the racemic product as described above. During the course of the development efforts, the following minimal requirements evolved for a technically viable catalytic system ee S80%, substrate to catalyst ratio (s/c) >50 000 and turnover fi-equency (tof) >10 000 h" . 

Although planar chirality has not been found in nature so far, biological tools can be used for resolution of planar chiral molecules. The synthesis of enantio-merically pure (S)-4-formyl[2.2]paracyclohane (>99% ee) (S)-155 and (R)-4-hydroxymethyl[2.2]paracyclophane (R)-156 (>78% ee) was achieved by bioreduction in 49 and 34% yield respectively. From several mircoorganisms screened only one strain of the yeast Saccharomyces cerevisiae showed a stereospecific reduction of the planar chiral substrate. Despite the high enantiomeric ratio it was necessary to maintain the conversion of the process at almost 50% in order to obtain high enantiomeric excesses of both substrate and reduction product [101]. 

Enantiomers show no difference in their reactions with achiral molecules, e.g., NaOH, HCl, and Brj. The situation is very different for reactions with chiral molecules or for reaetions in which chiral enzymes are involved. The typical biological process involves some chiral molecule undergoing reaction under the influence of a chiral enzyme. One enantiomer reacts rapidly while the other reacts at a much slower rate or does not react at all. The body can use one enantiomer efficiently but not the other. For example, o-glucose is utilized by the body but L-glucose cannot be utilized. L-Dopa is used to treat Parkinson s disease the o-enantiomer has no effect. Taste and odor also involve highly selective biochemical reactions. For example, (-)-carvone has the odor of caraway seeds while (-I- Fcarvone has the odor of spearmint. 

It can be seen, therefore, that biological processes (fermentation or simple enzymic transformations) can provide an environmentally friendly approach to large scale production of chiral molecules. There are, however, some drawbacks. Many processes involve aqueous conditions, some substrates deactivate the biocatalyst and therefore often products can only be accumulated at low concentration. This requires purification, which may itself produce substantial waste. 

Using chiral molecules, Dwyer discovered a phenomenon to which he gave the name configurational activity". Briefly, this means that the activity coefficients of optical isomers are different in an asymmetric environment provided by another optically active ion(7,34) He predicted that configurational activity should be of biological importance, since the rates of many enzyme processes should be changed by the addition of inert optically active complex ions(3 ). This work provided a better theoretical framewoik for the Pfeiffer effect and subsequently influenced the theory of chiral interactions. 

As discussed previously, different interactions between molecules, solvent, and substrate play an important role in two-dimensional crystal engineering. Another key factor which can strongly influence the outcome of the self-assembly process is chiralityThis structural aspect also assumes immense importance within a broad range of research domains such as catalysis and materials science. Separation of enantiomers is still a main concern in the pharmaceutical industry and the study of chirality on surfaces could be of great potential in this field. STM has been considered as an ideal technique to investigate the expression of chirality at a variety of interfaces with sub-molecular resolution.We focus on ambient conditions since it resembles the environment in which many important chemical and biological processes take place. 

---